{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:10:52Z","timestamp":1782504652887,"version":"3.54.5"},"reference-count":174,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CHDIF"},{"name":"NIH","award":["NS28721"],"award-info":[{"award-number":["NS28721"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.nbd.2012.03.025","type":"journal-article","created":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T05:35:33Z","timestamp":1332826533000},"page":"75-91","source":"Crossref","is-referenced-by-count":37,"title":["The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6\/2 Huntington's disease mice"],"prefix":"10.1016","volume":"47","author":[{"given":"A.","family":"Reiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.C.","family":"Lafferty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.B.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Del Mar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.P.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2012.03.025_bb0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410310412","article-title":"Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease","volume":"31","author":"Albin","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","article-title":"Functional architecture of basal ganglia circuits: neural substrates of parallel processing","volume":"13","author":"Alexander","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0015","author":"Allen Brain Atlas"},{"key":"10.1016\/j.nbd.2012.03.025_bb0020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2012.03.025_bb0025","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1152\/jn.01118.2005","article-title":"Altered cortical glutamate receptor function in the r6\/2 model of Huntington's disease","volume":"95","author":"Andre","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00439-007-0393-4","article-title":"NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner","volume":"122","author":"Arning","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.nbd.2012.03.025_bb0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2012.03.025_bb0040","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00005072-199704000-00013","article-title":"Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease\u2014an in situ hybridization study","volume":"56","author":"Arzberger","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1212\/WNL.42.2.460","article-title":"Immunocytochemical localization of ubiquitin in inclusion body myositis allows its light-microscopic distinction from polymyositis","volume":"42","author":"Askanas","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2012.03.025_bb0055","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","article-title":"Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor","volume":"24","author":"Baquet","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0865","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(97)00442-4","article-title":"In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats","volume":"229","author":"Battaglia","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2012.03.025_bb0050","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1582-4934.2010.01011.x","article-title":"Early defect of transforming growth factor \u03b21 formation in Huntington's disease","volume":"15","author":"Battaglia","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.nbd.2012.03.025_bb0060","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington's disease","volume":"11","author":"Beal","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0065","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate\u2013glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2012.03.025_bb0070","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/44.10.8813082","article-title":"NeuN: a useful neuronal marker for diagnostic histopathology","volume":"44","author":"Bluhmke","year":"1996","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.nbd.2012.03.025_bb0075","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1037\/0735-7044.117.6.1233","article-title":"Exploratory activity and fear conditioning abnormalities develop early in R6\/2 Huntington's disease transgenic mice","volume":"117","author":"Bolivar","year":"2003","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(99)00663-1","article-title":"LY379268, a potent and selective group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal cerebral ischemia","volume":"273","author":"Bond","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2012.03.025_bb0085","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0022-3565(24)39139-6","article-title":"Neuroprotective effects of LY379268, a selective mGluR2\/3 receptor agonist: investigations into possible mechanism of action in vivo","volume":"294","author":"Bond","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2012.03.025_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(91)90055-X","article-title":"Asymmetric increase in substance P immunoreactivity in the rat and guinea pig substantia nigra after unilateral neocortical ablation","volume":"133","author":"Bouras","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2012.03.025_bb0100","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1523\/JNEUROSCI.17-06-01891.1997","article-title":"The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial\u2013neuronal signaling","volume":"17","author":"Bruno","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0095","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.1523\/JNEUROSCI.18-23-09594.1998","article-title":"Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta","volume":"18","author":"Bruno","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0115","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1097\/00001756-199912160-00037","article-title":"Protection of neonatal rat brain from hypoxic\u2013ischemic injury by LY379268, a Group II metabotropic glutamate receptor agonist","volume":"10","author":"Cai","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2012.03.025_bb0105","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0110","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/1531-8257(200009)15:5<925::AID-MDS1025>3.0.CO;2-Z","article-title":"Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene","volume":"15","author":"Carter","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2012.03.025_bb0120","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2012.03.025_bb0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0130","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene","volume":"95","author":"Cha","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2012.03.025_bb0135","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1073\/pnas.94.13.7036","article-title":"In vivo activity-dependent plasticity at cortico\u2013striatal connections: evidence for physiological long-term potentiation","volume":"94","author":"Charpier","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2012.03.025_bb0140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","article-title":"Pharmacology and functions of metabotropic glutamate receptors","volume":"37","author":"Conn","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0860","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1471-4159.1995.64010101.x","article-title":"Activation of metabotropic glutamate receptors prevents neuronal apoptosis in culture","volume":"64","author":"Copani","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2012.03.025_bb0145","doi-asserted-by":"crossref","first-page":"8297","DOI":"10.1523\/JNEUROSCI.1889-07.2007","article-title":"The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration\/neuroprotection","volume":"27","author":"Corti","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0070-2153(06)75002-5","article-title":"Selective neuronal degeneration in Huntington's disease","volume":"75","author":"Cowan","year":"2006","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0155","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1460-9568.1997.tb01489.x","article-title":"Type 2 metabotropic glutamate (mGlu) receptors tonically inhibit transmitter release in rat caudate nucleus: in vivo studies with (2S,1\u2032S,2\u2032S,3\u2032R)-2-(2\u2032-carboxy-3\u2032-phenylcyclopropyl)glycine, a new potent and selective antagonist","volume":"9","author":"Cozzi","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0160","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington's disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2012.03.025_bb0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2012.03.025_bb0170","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2174\/1381612053381693","article-title":"Estrogen and cytokines production \u2014 the possible cause of gender differences in neurological diseases","volume":"11","author":"Czlonkowska","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2012.03.025_bb0175","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1476-5381.1995.tb16674.x","article-title":"Pharmacology of postsynaptic metabotropic glutamate receptors in rat hippocampal CA1 pyramidal neurones","volume":"116","author":"Davies","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0180","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the Huntington's disease mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2012.03.025_bb0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2010.07.022","article-title":"Neuropeptide Y modifies the disease course in the R6\/2 transgenic model of Huntington's disease","volume":"226","author":"Decressac","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jchemneu.2004.02.005","article-title":"Differential loss of striatal projection neurons in Huntington's disease: a quantitative immunohistochemical study","volume":"27","author":"Deng","year":"2004","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.nbd.2012.03.025_bb0205","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.neuroscience.2009.11.012","article-title":"Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain","volume":"165","author":"Di Liberto","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2012.03.025_bb0200","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2012.03.025_bb0210","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1471-4159.2001.00435.x","article-title":"Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways","volume":"78","author":"D'Onofrio","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2012.03.025_bb0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","article-title":"Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease","volume":"178","author":"Dorner","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2012.03.025_bb0220","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/81593","article-title":"Inactivation of the mouse Huntington's disease gene in the brain and testis results in progressive neurodegeneration and sterility","volume":"26","author":"Dragatsis","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2012.03.025_bb0225","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.nbd.2008.10.009","article-title":"CAG repeat lengths \u2265335 attenuate the phenotype in the R6\/2 Huntington's disease transgenic mouse","volume":"33","author":"Dragatsis","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2012.03.025_bb0230","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0149-7634(01)00022-7","article-title":"SEE: a tool for the visualization and analysis of rodent exploratory behavior","volume":"25","author":"Drai","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2012.03.025_bb0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0165-0270(99)00194-6","article-title":"Statistical discrimination of natural modes of motion in rat exploratory behavior","volume":"96","author":"Drai","year":"2000","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2012.03.025_bb0240","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0870","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1523\/JNEUROSCI.4356-06.2007","article-title":"Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease","volume":"27","author":"Fan","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0245","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0250","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","article-title":"Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease","volume":"24","author":"Ferrante","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/exnr.1994.1145","article-title":"Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats","volume":"129","author":"Figueredo-Cardenas","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0260","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2012.03.025_bb0265","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2012.03.025_bb0270","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.brainresrev.2008.12.001","article-title":"The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease","volume":"59","author":"Gil","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.nbd.2012.03.025_bb0275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1326-6-71","article-title":"Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction","volume":"6","author":"Giralt","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2012.03.025_bb0280","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2012.03.025_bb0285","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1523\/JNEUROSCI.23-17-06856.2003","article-title":"Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites","volume":"23","author":"Gorski","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0290","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2012.03.025_bb0295","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.5473-08.2009","article-title":"Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease","volume":"29","author":"Graham","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0300","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0315","doi-asserted-by":"crossref","first-page":"415","DOI":"10.18388\/abp.2004_3581","article-title":"Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease","volume":"51","author":"Hannan","year":"2004","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0320","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2012.03.025_bb0325","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the Huntington gene","volume":"14","author":"Hansson","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0305","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0310","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11064-007-9463-1","article-title":"Glutamate uptake is reduced in prefrontal cortex in Huntington's disease","volume":"33","author":"Hassel","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2012.03.025_bb0330","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nbd.2010.08.017","article-title":"Nicotinamide improves motor deficits and upregulates PGC-1a and BDNF gene expression in a mouse model of Huntington's disease","volume":"41","author":"Hathorn","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2012.03.025_bb0335","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(91)90583-F","article-title":"Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease","volume":"133","author":"Hedreen","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2012.03.025_bb0340","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1523\/JNEUROSCI.5599-08.2009","article-title":"In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease","volume":"29","author":"Heng","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0360","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","article-title":"Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice","volume":"157","author":"Hickey","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2012.03.025_bb0345","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","article-title":"Environmental enrichment slows disease progression in R6\/2 Huntington's disease mice","volume":"51","author":"Hockly","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0350","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2012.03.025_bb0355","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","article-title":"Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse","volume":"61","author":"Hockly","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2012.03.025_bb0365","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1527-3458.2007.00024.x","article-title":"The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268","volume":"13","author":"Imre","year":"2007","journal-title":"CNS Drug Rev."},{"issue":"R1","key":"10.1016\/j.nbd.2012.03.025_bb0370","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1093\/hmg\/ddq148","article-title":"Huntington's disease: progress toward effective disease-modifying treatments and a cure","volume":"9","author":"Johnson","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2012.03.025_bb0375","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","article-title":"Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease","volume":"29","author":"Joshi","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0380","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0165-0270(01)00392-2","article-title":"Natural segmentation of the locomotor behavior of drug-induced rats in a photobeam cage","volume":"109","author":"Kafkafi","year":"2001","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2012.03.025_bb0385","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1037\/0735-7044.117.3.464","article-title":"SEE locomotor behavior test discriminates C57BL\/6J and DBA\/2J mouse inbred strains across laboratories and protocol conditions","volume":"117","author":"Kafkafi","year":"2003","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0390","first-page":"108","article-title":"Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length","volume":"36","author":"Kehoe","year":"1999","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2012.03.025_bb0395","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1096\/fj.03-1075fje","article-title":"Estrogen and neuroprotection: higher constitutive expression of glutaredoxin in female mice offers protection against MPTP-mediated neurodegeneration","volume":"18","author":"Kenchappa","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2012.03.025_bb0400","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0028-3908(00)00118-0","article-title":"Activity-dependent presynaptic autoinhibition by group II metabotropic glutamate receptors at the perforant path inputs to the dentate gyrus and CA1","volume":"40","author":"Kew","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2012.03.025_bb0405","doi-asserted-by":"crossref","first-page":"31052","DOI":"10.1074\/jbc.M109.052969","article-title":"Identification of neuronal nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene family of splicing factors","volume":"284","author":"Kim","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2012.03.025_bb0410","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0028-3908(96)00140-2","article-title":"Dual action of metabotropic glutamate receptor agonists on neuronal excitability and synaptic transmission in spinal ventral horn neurons in vitro","volume":"35","author":"King","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2012.03.025_bb0415","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0014-2999(99)00397-0","article-title":"Neuroprotection by metabotropic glutamate receptor agonists: LY2354740, LY379268 and LY389795","volume":"377","author":"Kingston","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0420","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature09159","article-title":"Regulation of Parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry","volume":"466","author":"Kravitz","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2012.03.025_bb0425","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2012.03.025_bb0430","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2307\/2407630","article-title":"Quantitative genetic analysis of multivariate evolution, applied to brain: body size allometry","volume":"30","author":"Lande","year":"1979","journal-title":"Evolution"},{"key":"10.1016\/j.nbd.2012.03.025_bb0435","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1523\/JNEUROSCI.1990-04.2004","article-title":"Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats","volume":"24","author":"Lei","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0440","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0301-0082(03)00019-4","article-title":"Neurotrophin secretion: current facts and future prospects","volume":"69","author":"Lessmann","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0445","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1096\/fj.08-107268","article-title":"Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors","volume":"22","author":"Leveille","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2012.03.025_bb0460","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1073858404266777","article-title":"Huntingtin and its role in neuronal degeneration","volume":"10","author":"Li","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.nbd.2012.03.025_bb0450","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/hmg\/8.7.1227","article-title":"Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice","volume":"8","author":"Li","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2012.03.025_bb0455","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1152\/jn.00308.2004","article-title":"Enhanced striatal NR2B-containing N-methyl-d-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease","volume":"92","author":"Li","year":"2004","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0465","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/(SICI)1098-1136(20000201)29:3<222::AID-GLIA4>3.0.CO;2-0","article-title":"Characterization of striatal lesions produced by glutamate uptake alteration: cell death, reactive gliosis, and changes in GLT1 and GADD45 mRNA expression","volume":"29","author":"Lievens","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2012.03.025_bb0470","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington's disease transgenic mice","volume":"8","author":"Lievens","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2012.03.025_bb0475","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1152\/japplphysiol.00148.2004","article-title":"New replicable anxiety-related measures of wall vs center behavior of mice in the open field","volume":"97","author":"Lipkind","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0480","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0166-2236(96)10070-9","article-title":"Bursts as a unit of neural information: making unreliable synapses reliable","volume":"20","author":"Lisman","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0485","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/(SICI)1096-9861(19980615)395:4<450::AID-CNE3>3.0.CO;2-0","article-title":"Changes in subcellular localization of metabotropic glutamate receptor subtypes during postnatal development of mouse thalamus","volume":"395","author":"Liu","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0490","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","article-title":"Effects of ketamine and N-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268","volume":"117","author":"Lorrain","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2012.03.025_bb0495","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1152\/jn.1995.73.3.1076","article-title":"Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3","volume":"73","author":"Lovinger","year":"1995","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0500","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2012.03.025_bb0505","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2006.10.039","article-title":"Metformin therapy in a transgenic mouse model of Huntington's disease","volume":"411","author":"Ma","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2012.03.025_bb0510","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the Huntington's disease gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2012.03.025_bb0515","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.genm.2010.11.010","article-title":"Effects of gender in amyotrophic lateral sclerosis","volume":"7","author":"McCombe","year":"2010","journal-title":"Gend. Med."},{"key":"10.1016\/j.nbd.2012.03.025_bb0520","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0026-895X(25)09393-9","article-title":"Functional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells","volume":"50","author":"McCool","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0525","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/exnr.2000.7530","article-title":"Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease","volume":"166","author":"Meade","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0530","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cne.10295","article-title":"Localization of neuronal intranuclear inclusions (NIIs) in the striatum and cortex of the Bates R6\/2 transgenic mouse","volume":"449","author":"Meade","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0535","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7327","article-title":"Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease","volume":"162","author":"Menalled","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0540","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2012.03.025_bb0545","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1152\/jn.90606.2008","article-title":"Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease","volume":"100","author":"Miller","year":"2008","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0555","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1113\/jphysiol.2007.142448","article-title":"Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load","volume":"585","author":"Milnerwood","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0550","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/hmg\/ddl092","article-title":"Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease","volume":"15","author":"Milnerwood","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2012.03.025_bb0560","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early Increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2012.03.025_bb0565","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/jm9606756","volume":"40","author":"Monn","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2012.03.025_bb0570","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1021\/jm980616n","volume":"42","author":"Monn","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2012.03.025_bb0575","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.1073\/pnas.87.17.6723","article-title":"Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation","volume":"87","author":"Monsma","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2012.03.025_bb0580","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2008.11.015","article-title":"Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6\/2 mice","volume":"33","author":"Morton","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2012.03.025_bb0585","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1242\/dev.116.1.201","article-title":"NeuN, a neuronal specific nuclear protein in vertebrates","volume":"116","author":"Mullen","year":"1992","journal-title":"Development"},{"key":"10.1016\/j.nbd.2012.03.025_bb0595","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1126\/science.1329206","article-title":"Molecular diversity of glutamate receptors and implications for brain function","volume":"258","author":"Nakanishi","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.nbd.2012.03.025_bb0600","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/cne.903350209","article-title":"Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study","volume":"335","author":"Ohishi","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0605","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin","volume":"15","author":"Okamoto","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2012.03.025_bb0610","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2012.03.025_bb0615","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10654-007-9157-7","article-title":"Survival of Huntington's disease patients in Serbia: longer survival in female patients","volume":"22","author":"Pekmezovic","year":"2007","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0620","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2007.10.015","article-title":"The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2 Huntington's disease mouse model","volume":"210","author":"Peng","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0625","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00213-006-0372-9","article-title":"The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats","volume":"186","author":"Peters","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nbd.2012.03.025_bb0630","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/35049004","article-title":"Neurotrophins as synaptic modulators","volume":"2","author":"Poo","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0635","doi-asserted-by":"crossref","first-page":"RC202","DOI":"10.1523\/JNEUROSCI.22-02-j0006.2002","article-title":"Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington's disease gene","volume":"22","author":"Rebec","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0640","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neuroscience.2005.08.062","article-title":"Hyperactive striatal neurons in symptomatic Huntington R6\/2 mice: variations with behavioral state and repeated ascorbate treatment","volume":"137","author":"Rebec","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2012.03.025_bb0645","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0166-2236(99)01415-0","article-title":"Recent advances in understanding the pathogenesis of Huntington's disease","volume":"22","author":"Reddy","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0650","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/cne.902590106","article-title":"The distribution of proenkephalin-derived peptides in the central nervous system of turtle","volume":"259","author":"Reiner","year":"1987","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0655","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2012.03.025_bb0660","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cne.21515","article-title":"R6\/2 neurons with intranuclear inclusions survive for prolonged periods in the brains of chimeric mice","volume":"505","author":"Reiner","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0665","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2010.00142","article-title":"Corticostriatal projection neurons \u2014 dichotomous types and dichotomous functions","volume":"4","author":"Reiner","year":"2010","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.nbd.2012.03.025_bb0875","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0169-328X(97)00108-3","article-title":"Transforming growth factor-b protects human hNT cells from degeneration induced by beta-amyloid peptide: involvement of the TGF-b type II receptor","volume":"48","author":"Ren","year":"1997","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.nbd.2012.03.025_bb0670","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ana.410360406","article-title":"Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus","volume":"36","author":"Richfield","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0675","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(91)90448-3","article-title":"Heterogeneous dopamine receptor changes in early and late Huntington's disease","volume":"132","author":"Richfield","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2012.03.025_bb0680","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/ana.410380605","article-title":"Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients","volume":"38","author":"Richfield","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0685","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1109\/TSMC.1978.4310039","article-title":"Picture thresholding using an iterative selection method","volume":"8","author":"Ridler","year":"1978","journal-title":"IEEE Trans. Syst. Man Cybern."},{"key":"10.1016\/j.nbd.2012.03.025_bb0690","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/j.1471-4159.2008.05569.x","article-title":"Gender differences and estrogen effects in parkin null mice","volume":"106","author":"Rodr\u00edguez-Navarro","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2012.03.025_bb0695","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/jmg.28.8.515","article-title":"Age at onset in Huntington's disease: effect of line of inheritance and patient's sex","volume":"28","author":"Roos","year":"1991","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2012.03.025_bb0700","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","article-title":"ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease","volume":"103","author":"Ryu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2012.03.025_bb0705","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(94)00427-7","article-title":"Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis","volume":"64","author":"Sapp","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2012.03.025_bb0710","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/385630a0","article-title":"Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors","volume":"385","author":"Scanziani","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2012.03.025_bb0715","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mds.10229","article-title":"Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease","volume":"17","author":"Schiefer","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2012.03.025_bb0720","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2004.06.005","article-title":"The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's Disease","volume":"1019","author":"Schiefer","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2012.03.025_bb0725","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3565(24)29296-X","article-title":"Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system","volume":"299","author":"Schoepp","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2012.03.025_bb0730","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0028-3908(99)00092-1","article-title":"Pharmacological agents acting at subtypes of metabotropic glutamate receptors","volume":"38","author":"Schoepp","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2012.03.025_bb0735","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0278-5846(98)00070-0","article-title":"Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease","volume":"22","author":"Shear","year":"1998","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2012.03.025_bb0740","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2005.08.001","article-title":"Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease","volume":"21","author":"Shehadeh","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2012.03.025_bb0745","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0750","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.nbd.2010.10.015","article-title":"Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6\/2 mice","volume":"41","author":"Simmons","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2012.03.025_bb0755","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington's disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2012.03.025_bb0760","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0169-328X(90)90059-M","volume":"8","author":"Somers","year":"1990","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.nbd.2012.03.025_bb0765","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2012.03.025_bb0770","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequelae in R6\/2 Huntington's disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0775","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1523\/JNEUROSCI.4318-07.2007","article-title":"Neuroprotective effects of synaptic modulation in Huntington's disease R6\/2 mice","volume":"27","author":"Stack","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0780","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration","volume":"27","author":"Strand","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0785","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.1172871","article-title":"Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity","volume":"324","author":"Subramaniam","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.nbd.2012.03.025_bb0790","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/nbdi.2002.0554","article-title":"Differential changes in striatal projection neurons in R6\/2 mice transgenic for Huntington's disease","volume":"11","author":"Sun","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2012.03.025_bb0795","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.expneurol.2010.07.015","article-title":"Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6\/2 model of Huntington disease","volume":"225","author":"Tallaksen-Greene","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0800","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1523\/JNEUROSCI.21-12-04237.2001","article-title":"AMPA\/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter","volume":"21","author":"Tekkok","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0805","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1523\/JNEUROSCI.14-05-03005.1994","article-title":"Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat","volume":"14","author":"Testa","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0880","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington\u2019s disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0810","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0815","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jchemneu.2006.01.003","article-title":"Single-cell RT-PCR, in situ hybridization histochemical, and immunohistochemical studies of substance P and enkephalin co-occurrence in striatal projection neurons in rats","volume":"31","author":"Wang","year":"2006","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.nbd.2012.03.025_bb0820","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","article-title":"Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease","volume":"14","author":"Wolf","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2012.03.025_bb0825","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF Overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice","volume":"30","author":"Xie","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0830","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.npp.1300013","article-title":"Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex","volume":"28","author":"Zhai","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2012.03.025_bb0835","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1523\/JNEUROSCI.2384-06.2006","article-title":"Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala","volume":"26","author":"Zhao","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.025_bb0840","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2012.03.025_bb0845","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in HD","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nbd.2012.03.025_bb0850","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T02:12:26Z","timestamp":1742782346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996112000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":174,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0969996112000964"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2012.03.025","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}